Literature DB >> 26610306

The ketogenic diet in two paediatric patients with refractory myoclonic status epilepticus.

Roberto Horacio Caraballo1, Gabriela Reyes Valenzuela1, Marisa Armeno1, Sebastian Fortini1, Graciela Mestre1, Araceli Cresta1.   

Abstract

AIM: We describe two patients with refractory myoclonic status epilepticus treated with the ketogenic diet.
METHODS: Between May 1, 2014 and January 1, 2015, two patients who met the diagnostic criteria for refractory myoclonic status epilepticus, seen at our department, were placed on the ketogenic diet and followed for a minimum of six months.
RESULTS: One patient with myoclonic epilepsy of unknown aetiology had a 75-90% seizure reduction, and the other with progressive encephalopathy associated with myoclonic epilepsy had a 50% seizure reduction. Both patients retained good tolerability for the diet. At the last control, one patient had isolated myoclonias and EEG showed occasional generalized spike-and-polyspike waves; the patient is now successfully attending kindergarten. The quality of life of the second patient improved significantly. In both cases, the number of antiepileptic drugs was reduced.
CONCLUSION: The ketogenic diet is an effective and well-tolerated treatment option for patients with refractory myoclonic status epilepticus and should be considered earlier in the course of treatment.

Entities:  

Keywords:  ketogenic diet; myoclonias; seizures; status epilepticus; super-refractory

Mesh:

Year:  2015        PMID: 26610306     DOI: 10.1684/epd.2015.0781

Source DB:  PubMed          Journal:  Epileptic Disord        ISSN: 1294-9361            Impact factor:   1.819


  4 in total

Review 1.  The changing face of dietary therapy for epilepsy.

Authors:  Ludovica Pasca; Valentina De Giorgis; Joyce Ann Macasaet; Claudia Trentani; Anna Tagliabue; Pierangelo Veggiotti
Journal:  Eur J Pediatr       Date:  2016-09-01       Impact factor: 3.183

Review 2.  De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus.

Authors:  Conor S Ryan; Anthony L Fine; Alexander L Cohen; Brenda M Schiltz; Deborah L Renaud; Elaine C Wirrell; Marc C Patterson; Nicole J Boczek; Raymond Liu; Dusica Babovic-Vuksanovic; David C Chan; Eric T Payne
Journal:  J Child Neurol       Date:  2018-06-07       Impact factor: 1.987

3.  Dietary Management of Children With Super-Refractory Status Epilepticus: A Systematic Review and Experience in a Single UK Tertiary Centre.

Authors:  Natasha E Schoeler; Zoe Simpson; Runming Zhou; Suresh Pujar; Christin Eltze; J H Cross
Journal:  Front Neurol       Date:  2021-03-12       Impact factor: 4.003

Review 4.  Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.

Authors:  Laurent M Willems; Sebastian Bauer; Kolja Jahnke; Martin Voss; Felix Rosenow; Adam Strzelczyk
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.